For research use only. Not for therapeutic Use.
BET bromodomain inhibitor 3 is BET bromodomain inhibitor. BET bromodomain inhibitor 3 has inhibitory effect against BrdT with Ki value of > 40 µM. BET bromodomain inhibitor 3 can be used for the research of contraception, cancer, and heart disease[1].
BET bromodomain inhibitor 3 has inhibitory effect against BrdT with Ki value of > 40 µM[1].
Catalog Number | I041142 |
CAS Number | 854137-39-6 |
Synonyms | 11,13-dimethyl-8-(4-methylphenyl)-5-oxa-2,11,13-triazatricyclo[7.4.0.03,7]trideca-1(9),3(7)-diene-6,10,12-trione |
Molecular Formula | C18H17N3O4 |
Purity | ≥95% |
InChI | InChI=1S/C18H17N3O4/c1-9-4-6-10(7-5-9)12-13-11(8-25-17(13)23)19-15-14(12)16(22)21(3)18(24)20(15)2/h4-7,12,19H,8H2,1-3H3 |
InChIKey | AVGOOVXJYOSRNE-UHFFFAOYSA-N |
SMILES | CC1=CC=C(C=C1)C2C3=C(COC3=O)NC4=C2C(=O)N(C(=O)N4C)C |
Reference | [1]. Ayoub AM, et al. BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen [published correction appears in J Med Chem. 2017 Jul 27;60(14):6458]. J Med Chem. 2017;60(12):4805-4817. |